Potent and specific antitumor effect of CEA-targeted photoimmunotherapy

International Journal of Cancer

Volumn 135, Issue 11, 2014, Pages 2697-2710

  Shirasu, Naoto ^a   Yamada, Hiromi ^a   Shibaguchi, Hirotomo ^a   Kuroki, Motomu ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Bioluminescence imaging; Carcinoembryonic antigen; Near infrared light; Photodynamic therapy; Photoimmunoconjugate; Photoimmunotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CASPASE; DYE; INFRARED DYE; LUCIFERASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; FLUORESCENT DYE; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT;

ADENOCARCINOMA CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL MEMBRANE; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; IMAGING; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LIPID PEROXIDATION; MOLECULARLY TARGETED THERAPY; MOUSE; NEAR INFRARED IRRADIATION; NONHUMAN; NONINVASIVE BIOLUMINESCENCE IMAGING; PHOTOIMMUNOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; NEOPLASMS; NUDE MOUSE; PHOTOCHEMOTHERAPY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMMUNOCONJUGATES; IMMUNOTHERAPY; LIPID PEROXIDATION; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84921676998     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28907     Document Type: Article

References (40)

1. Master A, Livingston M, Sen Gupta A. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 2013;168:88-102.
2. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011;61:250-81.
3. Yoo JO, Ha KS. New insights into the mechanisms for photodynamic therapy-induced cancer cell death. Int Rev Cell Mol Biol 2012;295:139-74.
4. Mroz P, Yaroslavsky A, Kharkwal GB, et al. Cell death pathways in photodynamic therapy of cancer. Cancers 2011;3: 2516-39.
5. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991;53:549-53.
6. Triesscheijn M, Baas P, Schellens JH, et al. Photodynamic therapy in oncology. Oncologist 2006; 11:1034-44.
7. Lutsenko SV, Feldman NB, Finakova GV, et al. Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates. Tumour Biol 1999;20:218-24.
8. Song L, Li H, Sunar U, et al. Naphthalocyaninereconstituted LDL nanoparticles for in vivo cancer imaging and treatment. Int J Nanomed 2007; 2:767-74.
9. Savellano MD, Pogue BW, Hoopes PJ, et al. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res 2005;65:6371-9.
10. Gupta S, Dwarakanath BS, Chaudhury NK, et al. In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. J Cancer Res Ther 2011;7: 314-24.
11. Kuimova MK, Bhatti M, Deonarain M, et al. Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosensitizer conjugates suitable for photodynamic therapy. Photochem Photobiol Sci 2007;6:933-9.
12. Staneloudi C, Smith KA, Hudson R, et al. Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer. Immunology 2007;120:512-7.
13. Shirasu N, Nam SO, Kuroki M. Tumor-targeted photodynamic therapy. Anticancer Res 2013;33: 2823-31.
14. Bullous AJ, Alonso CM, Boyle RW. Photosensitiser-antibody conjugates for photodynamic therapy. Photochem Photobiol Sci 2011;10:721-50.
15. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010;16:5928-35.
16. O'Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009;85:1053-74.
17. Mitsunaga M, Nakajima T, Sano K, et al. Nearinfrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem 2012; 23:604-9.
18. Mitsunaga M, Ogawa M, Kosaka N, et al. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011;17:1685-91.
19. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001;19:316-7.
20. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624-30.
21. Kuroki M, Ueno A, Matsumoto H, et al. Significance of tumor-associated antigens in the diagnosis and therapy of cancer: an overview. Anticancer Res 2002;22:4255-64.
22. Imakiire T, Kuroki M, Shibaguchi H, et al. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen. Int J Cancer 2004;108: 564-70.
23. HuangJ,ShibaguchiH,ZhaoJ,etal.IgGisotypeconversionofanovelhumananti-carcinoembryonicantigen antibodytoincreaseitsbiologicalactivity.Anticancer Res2006;26:1057-63.
24. Zhao J, Kuroki M, Shibaguchi H, et al. Recombinant human monoclonal IgA antibody against CEA to recruit neutrophils to CEA-expressing cells. Oncol Res 2008;17:217-22.
25. Tanaka T, Huang J, Hirai S, et al. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res 2006;12: 3803-13.
26. Shirasu N, Shibaguci H, Kuroki M, et al. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen. Anticancer Res 2010;30:2731-8.
27. Abe H, Kuroki M, Imakiire T, et al. Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients. J Immunol Methods 2002;270:227-33.
28. Pap EH, Drummen GP, Winter VJ, et al. Ratiofluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591). FEBS Lett 1999;453:278-82.
29. Kaiser PK. Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration. Curr Med Res Opin 2007;23:477-87.
30. Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; What is the appropriate target? Theranostics 2013;4:81-9.
31. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136-51.
32. Mew D, Wat CK, Towers GH, ET AL. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibodyhematoporphyrin conjugates. J Immunol 1983; 130:1473-7.
33. Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 1996;47:555-606.
34. Liu L, Zhang Z, Xing D. Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage. Free Radic Biol Med 2011;51:53-68.
35. Ge Y, Weng X, Tian T, et al. A mitochondriatargeted zinc(ii) phthalocyanine for photodynamic therapy. RSC Adv 2013;3:12839-46.
36. Oliveira CS, Turchiello R, Kowaltowski AJ, et al. Major determinants of photoinduced cell death: subcellular localization versus photosensitization efficiency. Free Radic Biol Med 2011;51: 824-33.
37. Wang K, Wu X, Wang J, et al. Cancer stem cell theory: therapeutic implications for nanomedicine. Int J Nanomed 2013;8:899-908.
38. Thomas C, Pardini RS. Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol 1992;55:831-7.
39. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985;45: 1608-10.
40. Okazaki S, Suzuki N. Investigation of the photosensitizing property of near-infrared fluorescentlabeling reagent IRDye700DX. J Jpn Soc Laser Med 2012;33:204.